The National Health Surveillance Agency (Anvisa) hosted for the first time the Fórum Anual do Programa de Auditoria Única de Dispositivos Médicos (Annual Forum of the Medical Device Single Audit Program) (MDSAP), between October 23rd and 27th, in which participants learned about regulatory updates on the program with Auditing Bodies and the regulated sector. ABIMED was one of the speakers, discussing the experience, benefits and challenges of certification via MDSAP.

The healthcare authorities who are members of the Program had the opportunity to discuss the results and improvements in the MDSAP and plan next year’s activities.

Implemented in 2017, MDSAP is increasingly being used to certify manufacturing plants. In 2022, 59.7% of Good Manufacturing Practices Certificates (GMP) were issued through the program. So far this year, 62.6% of projects have benefited from the initiative.